← Back to headlines
FDA Grants Breakthrough Status to Johnson & Johnson's Cancer Drug for Advanced Head and Neck Cancer
The FDA has granted Breakthrough Therapy Designation to Johnson & Johnson's cancer drug, JNJ-73841937, for the treatment of advanced head and neck cancer.
21 Feb, 16:31 — 21 Feb, 16:31
Sources
Showing 1 of 1 sources
Related Stories
Toxic Smoke from Navotas Landfill Fire Reaches Bulacan Villages
just now
Financial Barriers Hinder Vaccine Access in Philippines
just now
Polish Employers Consider Time Off for Preventive Health Check-ups
15m ago
German Health Minister's Reform Criticized for Impact on Workers and Unaddressed Savings
22m ago